| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/15/2013 | US8354510 Mutant protein |
| 01/15/2013 | US8354504 Chimeric isoprenoid synthases and uses thereof |
| 01/15/2013 | US8354500 Cytolethal distending toxins and detection of campylobacter bacteria using the same as a target |
| 01/15/2013 | US8354498 CD4 mimic peptides and their uses |
| 01/15/2013 | US8354497 Peptide binding to methylated DNA |
| 01/15/2013 | US8354496 Isoforms of brain natriuretic peptide |
| 01/15/2013 | US8354380 NY-ESO-1 peptide analogs |
| 01/15/2013 | US8354378 G protein coupled receptor antagonists and methods of activating and inhibiting G protein coupled receptors using the same |
| 01/15/2013 | US8354376 Osteogenic devices and methods of use thereof for repair of endochondral bone, osteochondral and chondral defects |
| 01/15/2013 | US8354273 Isoforms of human somatostatin receptor type 5 |
| 01/15/2013 | US8354272 Zinc-regulated prokaryotic expression cassettes |
| 01/15/2013 | US8354268 Protein glycosylation modification in methylotrophic yeast |
| 01/15/2013 | US8354241 Methods for identifying a GLP-1 secretagogue |
| 01/15/2013 | US8354240 VMP-like sequences of pathogenic Borrelia |
| 01/15/2013 | US8354108 Fully human antibody to human TNFα, molecular evolution and use thereof |
| 01/15/2013 | CA2687632C Lyophilised antigen composition |
| 01/15/2013 | CA2631587C Chemokine-mucin fusions linked to glycosylphosphatidylinositol (gpi)-anchors in tissue regeneration and as tumour immune adjuvants |
| 01/15/2013 | CA2550583C Modified cea /b7 vector |
| 01/15/2013 | CA2529828C Factor vii or viia gla domain variants |
| 01/15/2013 | CA2489186C Chemical synthesis of reagents for peptide coupling |
| 01/15/2013 | CA2466156C Ehrlichia disulfide bond formation proteins and uses thereof |
| 01/15/2013 | CA2451864C Methods of inducing a cytotoxic immune response and recombinant simian adenovirus compositions useful therein |
| 01/15/2013 | CA2443323C Nucleic acid vaccines for prevention of flavivirus infection |
| 01/15/2013 | CA2409031C Insecticidal secreted proteins of brevibacillus laterosporus |
| 01/15/2013 | CA2406725C Edg8 receptor, its preparation and use |
| 01/15/2013 | CA2400842C Novel compounds |
| 01/15/2013 | CA2322449C Biosynthetic genes for spinosyn insecticide production |
| 01/14/2013 | CA2782916A1 Host cells and methods for producing fatty acid |
| 01/10/2013 | WO2013006861A1 Sorghum grain shattering gene and uses thereof in altering seed dispersal |
| 01/10/2013 | WO2013006838A1 Immunogenic combination compositions and uses thereof |
| 01/10/2013 | WO2013006730A2 Biological methods for preparing a fatty dicarboxylic acid |
| 01/10/2013 | WO2013006722A1 Hcv genotype 3 replicons |
| 01/10/2013 | WO2013006721A1 Hcv genotype 4 replicons |
| 01/10/2013 | WO2013006675A1 Albumin formulation and use |
| 01/10/2013 | WO2013006547A2 Antibodies against epidermal growth factor receptor (egfr) and uses thereof |
| 01/10/2013 | WO2013006544A1 Methods for making multimeric polypeptides |
| 01/10/2013 | WO2013006076A1 The use of intranasally administered hsp70 protein to treat neurodegenerative diseases |
| 01/10/2013 | WO2013006058A1 Use of jaz5a for improving drought-resistance in a plant |
| 01/10/2013 | WO2013006050A1 Peptides inducing or enhancing an immune response against prostate-specific membrane protein (PSMA) |
| 01/10/2013 | WO2013005839A1 Phosphorylated peptide, hard tissue and/or ectopic calcification inhibitor, antibody, and hard tissue and/or ectopic calcification promoter |
| 01/10/2013 | WO2013005603A1 Agent for prevention and/or treatment of allergic inflammation in conjunctiva |
| 01/10/2013 | WO2013004983A1 Novel compounds and their effects on feeding behaviour |
| 01/10/2013 | WO2013004906A1 Improving the production of foreign proteins |
| 01/10/2013 | WO2013004717A1 Biochemical markers for neurodegenerative conditions |
| 01/10/2013 | WO2013004607A1 Relaxin fusion polypeptides and uses thereof |
| 01/10/2013 | WO2013004587A1 Method for separation of monomeric polypeptides from aggregated polypeptides |
| 01/10/2013 | WO2012158965A3 Improved peptide pharmaceuticals for insulin resistance |
| 01/10/2013 | WO2012158964A3 Improved peptide pharmaceuticals for osteoporosis |
| 01/10/2013 | WO2012142171A3 Improved cellulase variants |
| 01/10/2013 | WO2012141554A3 Complex in which an anti-cotinine antibody is bound to a binder material of cotinine and a binding substance, and a use therefor |
| 01/10/2013 | US20130012690 Method for stabilization of proteins using non-natural amino acids |
| 01/10/2013 | US20130012687 Inducible self-cleaving protease tag and method of purifying recombinant proteins using the same |
| 01/10/2013 | US20130012685 Novel peptides that bind to the erythropoietin receptor |
| 01/10/2013 | US20130012684 Purification Method |
| 01/10/2013 | US20130012571 Organic Compositions to Treat Beta-ENaC-Related Diseases |
| 01/10/2013 | US20130012456 Compositions and methods for transport across the blood brain barrier |
| 01/10/2013 | US20130012455 Use of ARC for inhibiting cell death during liver failure |
| 01/10/2013 | US20130012442 Von willebrand factor- and factor viii-polymer conjugates having a releasable linkage |
| 01/10/2013 | US20130012437 Lytic peptides having anti-proliferative activity against prostate cancer cells |
| 01/10/2013 | US20130012436 Fibronectin based scaffold domain proteins that bind il-23 |
| 01/10/2013 | US20130012435 Multivalent fibronectin based scaffold domain proteins |
| 01/10/2013 | US20130012427 Polypeptides |
| 01/10/2013 | US20130011900 Nucleophilic catalysts for oxime linkage |
| 01/10/2013 | US20130011876 Process for preparing filamentous fungal strains having a sexual cycle and a process for preparing sexually crossed filamentous fungal strains |
| 01/10/2013 | US20130011432 Disrupted adenovirus-based vaccine against drugs of abuse |
| 01/10/2013 | US20130011428 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 01/10/2013 | US20130011426 Recombinant Vaccines and Use Thereof |
| 01/10/2013 | US20130011425 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 01/10/2013 | US20130011422 Tumor Antigens for the Prevention and/or Treatment of Cancer |
| 01/10/2013 | US20130011404 Methods and Compositions for Regulating Musashi Function |
| 01/10/2013 | US20130011403 Klebsiella antigens |
| 01/10/2013 | US20130011402 Compositions and methods for the diagnosis and treatment of tumor |
| 01/10/2013 | US20130011382 Fibrinogen Preparations Enriched In Fibrinogen With An Extended Alpha Chain |
| 01/10/2013 | US20130011375 T cell receptors specific for immunodominant ctl epitopes of hcv |
| 01/10/2013 | US20130011367 Promoters Exhibiting Endothelial Cell Specificity and Methods of Using Same for Regulation of Angiogenesis |
| 01/10/2013 | US20130011362 Targeting monomers and polymers having targeting blocks |
| 01/10/2013 | US20130011356 Hair-binding peptides |
| 01/10/2013 | US20130011338 Cupredoxin derived transport agents and methods of use thereof |
| 01/10/2013 | US20130011334 Modified ubiquitin proteins having a specific binding activity for the extradomain b of fibronectin |
| 01/10/2013 | DE112009003677T5 Pflanzenwachstum fördernder Proteinkomplex Plant growth-promoting protein complex |
| 01/10/2013 | CA2841794A1 Biological methods for preparing a fatty dicarboxylic acid |
| 01/10/2013 | CA2840989A1 Immunogenic combination compositions and uses thereof |
| 01/10/2013 | CA2840868A1 Hcv genotype 4 replicons |
| 01/10/2013 | CA2840828A1 Hcv genotype 3 replicons |
| 01/10/2013 | CA2840552A1 Relaxin fusion polypeptides and uses thereof |
| 01/10/2013 | CA2840221A1 P97-antibody conjugates and methods of use |
| 01/10/2013 | CA2840162A1 Constitutively active aba receptor mutants |
| 01/10/2013 | CA2840088A1 Antibodies against epidermal growth factor receptor (egfr) and uses thereof |
| 01/10/2013 | CA2839840A1 Use of jaz5a for improving drought-resistance in a plant |
| 01/10/2013 | CA2838964A1 Albumin formulation and use |
| 01/09/2013 | EP2544005A1 Gastric cancer marker, and method for detecting gastric cancer |
| 01/09/2013 | EP2544004A1 Gastric cancer marker, and method for detecting gastric cancer |
| 01/09/2013 | EP2543733A1 Plants having improved characteristics and a method for making the same |
| 01/09/2013 | EP2543387A1 Mucosal vaccine |
| 01/09/2013 | EP2542703A2 Novel hiv-1 envelope glycoprotein |
| 01/09/2013 | EP2542686A1 Compositions and methods for bacterial production of chondroitin |
| 01/09/2013 | EP2542681A2 Protein and nucleic acid delivery vehicles, components and mechanisms thereof |
| 01/09/2013 | EP2542679A1 B-cell stimulating fusion proteins of an antigen with baff or april |
| 01/09/2013 | EP2542590A2 Compositions and methods for targeted immunomodulatory antibodies and fusion proteins |
| 01/09/2013 | EP2542574A2 Method for producing soluble recombinant interferon protein without denaturing |